Next Article in Journal
Seasonal Variation of Bioactive Alkaloid Contents in Macleaya microcarpa (Maxim.) Fedde
Previous Article in Journal
Salidroside Attenuates Hydrogen Peroxide-Induced Cell Damage Through a cAMP-Dependent Pathway
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Simple and Efficient Synthesis of Racemic 2-(tert-Butoxycarbon-ylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic Acid, a New Derivative of β-(1,2,4-Triazol-1-yl)alanine

1
Laboratoire de Chimie Organique Fès, Faculté des Sciences Dhar El Mahraz, Université Sidi Mohamed Ben Abdellah, Morocco
2
Centre Universitaire Régional d’Interface (CURI), Université Sidi Mohamed Ben Abdellah, Fès, Morocco
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(4), 3380-3390; https://doi.org/10.3390/molecules16043380
Submission received: 15 March 2011 / Revised: 7 April 2011 / Accepted: 11 April 2011 / Published: 19 April 2011
(This article belongs to the Section Organic Chemistry)

Abstract

:
A simple synthetic approach to racemic N-tert-butyloxycarbonyl-2-methyl-3-(1H-1,2,4-triazol-1-yl)alanine (5) in four steps and 68% overall yield starting from oxazoline derivative 1 is reported. This synthesis involves the alkylation of 1H-1,2,4-triazole with an O-tosyloxazoline derivative, followed by an oxazoline ring-opening reaction and oxidation of the N-protected β‑aminoalcohol by potassium permanganate.

1. Introduction

Triazoles constitute an important class of biologically active heterocyclic compounds that have received a great deal of attention since their discovery. Diverse compounds derived from 1,2,4-triazoles have a wide spectrum activities, including antimicrobial [1,2] and antibacterial properties [3,4], human antifungal agents [5], anticancer agents [6], antiviral [7], antitumor activity [8], inhibitors of cytochrome P450 14α-demethylase (CYP51) [9] and in agricultural science as potent fungicides, herbicides and insecticides [10,11]. Amino acids containing the 1,2,4-triazole moiety and their derivatives represent a well-known group of organic compounds also presenting biological activity. Thus β-(1,2,4-triazol-1-yl)-L-alanine is known as an important metabolite in plants of the fungicide myclobutanil [12,13,14] and β-(3-amino-1,2,4-triazol-1-yl)-L-alanine is a metabolite of the weedkiller 3-amino-1,2,4-triazole [15]. Considering the interest in these heterocyclic amino acids, several structurally related nonproteinogenic amino acids and their derivatives have been the subject of various investigations. For example, preparation of methyl 2-(bis(tert-butoxycarbonyl)amino)-3-(1H-1,2,4-triazol-1-yl)-propanoate, a derivative of β-(l,2,4-triazol-l-yl)-alanine by a Michael addition of 1H-1,2,4-triazole to N,N-bis(tert-butyloxycarbonyl)dehydroalanine methyl ester has been described [16]. The same authors also described the synthesis of methyl 2-(N-(tert-butoxycarbonyl)benzamido)-3-(1H-1,2,4-triazol-1-yl)butanoate [17] according to the same reaction process mentioned previously.
Continuing our investigations in the use of oxazoline derivative in heterocyclic synthesis [18,19,20] we present herein a convenient and easy procedure for the preparation of racemic N-tert-butyloxy-carbonyl-2-methyl-3-(1H-1,2,4-triazol-1-yl)alanine, a new derivative of β-(1,2,4-triazol-1-yl)alanine.

2. Results and Discussion

Our strategy for the synthesis of N-tert-butyloxycarbonyl-2-methyl-3-(1H-1,2,4-triazol-1-yl)alanine 5 is based on the substitution of the O-tosyl group present in the oxazoline ring with 1H-1,2,4-triazole (Scheme 1). It is reported that, the alkylation of 1,2,4-triazole with alkyl halides and a variety of bases afforded the corresponding 1- and 4-alkylated isomers, with prevalence of the N1-isomer [21,22,23]. Reaction of 1H-1,2,4-triazole with 1 and K2CO3, was carried out in the presence of a catalytic amount of tetrabutylammonium bromide in N,N’-dimethylformamide at 120 °C for 12 hours.
Scheme 1. Strategy of synthesis of compound 5.
Scheme 1. Strategy of synthesis of compound 5.
Molecules 16 03380 g006
Application of our method to 1,2,4-triazole afforded only the 1-substituted product, and after column chromatography on silica gel we isolated only one isomer. Product 2 was obtained in 95% yield from 1 and was characterized by MS, 1H-NMR and 13C-NMR spectroscopy. The structure of N1-isomer 2 was assigned by comparison with the literature data [16,21,22,23] concerning the chemical shifts of triazole protons and the chemical shifts of the carbons of the triazole ring in positions 3' and 5' (see Scheme 1). Indeed, the 1H-NMR spectrum of 2 show two signals at 7.88 and 8.17 ppm for the two triazole protons (H5'triazole, H3'triazole) which are not equivalent. In the same way, the 13C-NMR spectrum of 2 also shows two signals at 151.42 and 144.32 ppm relating to the carbons of the triazole ring in positions 3' and 5'.
The preceding reaction stage is followed by an oxazoline ring-opening reaction carried out in acidic medium. The aminoalcohol derivative 3 was obtained in 97% yield. The addition of Boc2O to the product 3 in a mixture of water/dioxane in the presence of triethylamine leads to N-protected-β-aminoalcohol 4 (yield 80%).
The action of dilute KMnO4 on compound 4 in basic medium (NaOH) led after four hours at room temperature to N-tert-butyloxycarbonyl-2-methyl-3-(1H-1,2,4-triazol-1-yl)alanine (5) in a yield of 92%. The structures of products 4 and 5 were established on the basis of NMR spectroscopy (1H, 13C and 15N), MS data and elemental analysis. The definite assignment the chemical shifts of protons, carbons and nitrogens (products 4 and 5) are shown in Table 1, Table 2 and Table 3.
Table 1. 1H (300 MHz) and 13C (75.47 MHz) NMR spectral data for compound 4 in DMSO-d6, including results obtained by homonuclear 2D shift-correlated and heteronuclear 2D shift-correlated HMQC (1JCH)a. Chemical shifts (δ, ppm) and coupling constants (J, Hz, in parenthesis)b.
Table 1. 1H (300 MHz) and 13C (75.47 MHz) NMR spectral data for compound 4 in DMSO-d6, including results obtained by homonuclear 2D shift-correlated and heteronuclear 2D shift-correlated HMQC (1JCH)a. Chemical shifts (δ, ppm) and coupling constants (J, Hz, in parenthesis)b.
PositionδHδCCorrelation 1H-1HCorrelation 1H-13C
(NH) 16.29 (s)-1-H-
2-56.66--
33.35, 3.45 (AB (2dd), 10.8; 5.6)64.85H1-3, H2-3, O-HH1-3, H2-3, C-3
(OH) 44.92 (t, 5.6)-O-H, H1-3, H2-3-
51.18 (s)20.43H1-5, H2-5, H3-5H1,2,3-5; C-5
64.35, 4.51 (AB, 14)51.74H1-6, H2-6H1-6, H2-6, C-6
97.95 (s)151.61H3'triazole -9H3'triazole -9, C-9
118.23 (s)145.24H5'-triazole -11H5'-triazole -11, C-11
12-154.97--
14-78.43--
H1,2,3-15H1,2,3-15; C-15
15; 17; 181.39 (s)28.68H1,2,3-17H1,2,3-17; C-17
H1,2,3-18H1,2,3-18; C-18
a) Correlation from C to the indicated hydrogens; b) Chemical shifts and coupling constants (J) obtained from the 1D 1H-NMR spectrum.
Table 2. Listing of 15N (400 MHz) NMR spectral data for 4 in DMSO-d6, including results obtained by heteronuclear single quantum coherence shift-correlated (HSQC) and heteronuclear multiple bond coherence shift-correlated (HMBC).
Table 2. Listing of 15N (400 MHz) NMR spectral data for 4 in DMSO-d6, including results obtained by heteronuclear single quantum coherence shift-correlated (HSQC) and heteronuclear multiple bond coherence shift-correlated (HMBC).
PositionδHδNCorrelation 1H-15N
1 (HN)7.02 (s)94.23H-1,N-1
51.24 (s)93.29H1,2,3-5, N-1
64.39, 4.83 (AB, 14)93.03H1,2-6, N-1
214.36H1,2-6, N-7
299.27H1,2-6, N-8
97.96 (s)214.58H3'triazole-9, N-7
252.01H3'triazole-9, N-10
299.06H3'triazole-9, N-8
118.20 (s)214.58H5'-triazole-11, N-7
252.01H5'-triazole-11, N-10
Chemical shifts (δ, ppm) and coupling constants (J, Hz, in parenthesis) obtained from the 1D 1H-NMR spectrum
Table 3. 1H (300 MHz) and 13C (75.47 MHz) NMR spectral data for 5 in DMSO-d6, including results obtained by homonuclear 2D shift-correlated and heteronuclear 2D shift-correlated HMQC (1JCH) a. Chemical shifts (δ, ppm) and coupling constants (J, Hz, in parenthesis) b.
Table 3. 1H (300 MHz) and 13C (75.47 MHz) NMR spectral data for 5 in DMSO-d6, including results obtained by homonuclear 2D shift-correlated and heteronuclear 2D shift-correlated HMQC (1JCH) a. Chemical shifts (δ, ppm) and coupling constants (J, Hz, in parenthesis) b.
PositionδHδCCorrelation 1H-1HCorrelation 1H-13C
(NH)17.02 (s)-1-H-
2-58.24--
3-174.53--
(OH)412.73 (br, s)---
51.24 (s)22.33H1-5, H2-5, H3-5H1,2,3-5; C-5
64.39, 4.83 (AB, 14)52.06H1-6, H2-6H1-6, H2-6, C-6
97.96 (s)151.63H3'triazole -9H3'triazole -9, C-9
118.20 (s)145.56H5'-triazole -11H5'-triazole -11, C-11
12-155.02--
14-78.95--
H1,2,3-15H1,2,3-15; C-15
15; 17; 181.40 (s)28.64H1,2,3-17H1,2,3-17; C-17
H1,2,3-18H1,2,3-18; C-18
a) Correlation from C to the indicated hydrogens; b) Chemical shifts and coupling constants (J) obtained from the 1D 1H-NMR spectrum.
In the homonuclear 1H-1H 2D spectra of 4 (Figure 1) two bond connectivity (1JH-H) between H1-6;H2-6 and H1-3;H2-3 can be observed, whereas in the homonuclear 1H-1H 2D spectra of 5 (Figure 2), we just observed two bond connectivity between H1-6;H2-6 and that of H1-3;H2-3 is absent, indicating the formation of the carboxylic acid.
In the same way, in the heteronuclear 1H-13C 2D spectra of 4 (Figure 3), the correlation of C-3 and H1-3; H2-3 is present, whereas this one is absent in the heteronuclear 1H-13C 2D spectra of 5 (Figure 4). Moreover, the carboxyl group resonated at 12.73 ppm and 174.53 ppm in the 1H- and 13C-NMR spectra of compound 5. In addition, the analysis of 15N NMR spectrum of 4 confirms the N1-isomer structure (Figure 5).
Figure 1. Homonuclear 1H-1H 2D spectrum for compound 4 between 3 and 6.5 ppm.
Figure 1. Homonuclear 1H-1H 2D spectrum for compound 4 between 3 and 6.5 ppm.
Molecules 16 03380 g001
Figure 2. Homonuclear 1H-1H 2D spectrum for compound 5.
Figure 2. Homonuclear 1H-1H 2D spectrum for compound 5.
Molecules 16 03380 g002
Figure 3. Heteronuclear 1H-13C 2D spectrum for compound 4.
Figure 3. Heteronuclear 1H-13C 2D spectrum for compound 4.
Molecules 16 03380 g003
Figure 4. Heteronuclear 1H-13C 2D spectrum for compound 5.
Figure 4. Heteronuclear 1H-13C 2D spectrum for compound 5.
Molecules 16 03380 g004
Figure 5. HMBC 1H–15N spectrum for compound 4.
Figure 5. HMBC 1H–15N spectrum for compound 4.
Molecules 16 03380 g005

3. Experimental

3.1. General

All solvents were purified following the standard techniques and commercial reagents were purchased from Sigma Aldrich and Fluka. Melting points were determined with an Electrothermal melting point apparatus and are uncorrected. NMR spectra (1H, 13C and 15N) were recorded on a Bruker AM 300 (operating at 300.13 MHz for 1H, at 75.47 MHz for 13C and at 30.41 MHz for 15N) spectrometer (Centre Universitaire Régional d’Interface, Fez). NMR data are listed in ppm and are reported relative to tetra-methylsilane (1H, 13C); residual solvent peaks being used as internal standard. All reactions were followed by TLC. TLC analyses were carried out on 0.25 mm thick precoated silica gel plates (Merck Fertigplatten Kieselgel 60F254) and spots were visualised under UV light or by exposure to vaporised iodine. Mass spectra were recorded on a PolarisQ Ion Trap GC/MS Mass Spectrometer (Centre Universitaire Régional d’Interface, Fez). Elemental analyses were done in Central Service of Analysis at Rabat. The O-tosyl oxazoline derivative (1) was prepared in two steps from the commercially available 2-amino-2-methylpropane-1,3-diol using El Hajji’s method [18].

3.2. 4-((1H-1,2,4-Triazol-1-yl)methyl)-4-methyl-2-phenyl-4,5-dihydrooxazole (2)

To a solution of 1H-1,2,4-triazole (0.35 g, 5 mmol) in N,N’-dimethylformamide (12 mL), potassium carbonate (K2CO3, 0.68 g, 5 mmol) was added by a small portions along with a catalytic quantity of tetra-n-butylammonium bromide (TBAB). The mixture is left stirring for 30 minutes, then O-tosyl oxazoline derivative 1 (0.35 g, 1 mmol) is added. The reaction mixture was heated to 120 °C for 12 hours with stirring. After cooling, the solvent is evaporated under vacuum and the product was extracted with ethyl acetate and then washed with water. The organic layer was dried on sodium sulfate, concentrated. The oil obtained is purified by column chromatography on silica gel using ether/methanol 5% to afford the pure N-alkylated product 2. Yield 95%; Mol.Wt: 242; Rf = 0.31 (ether/ methanol: 9/1); 1H-NMR (CDCl3, δ ppm): 1.38 (s, 3H, CH3); 4.05, 4.59 (AB, 2H, J = 8.9 Hz, CH2O), 4.31 and 4.37 (AB, 2H, J = 14.2Hz, CH2N), 7.28-7.82 (m, 5Harom), 7.88 (s, 1Htriazole), 8.17(s, 1Htriazole). 13C-NMR (CDCl3, δ ppm): 24.82 (CH3), 56.97 (1C, 4,5-dihydrooxazole), 70.44(1C, CH2-triazole), 75.01(1C, CH2 (4,5-dihydrooxazole)), 128.26, 128.43, 131.90, 133.44 (6C, phenyl), 144.32 and 151.42 (2C, triazole), 164.76(1C, 4,5-dihydrooxazole), MS m/z (%): 242.99 [M+1] (100), 174.05 (18), 160.07 (10).

3.3. 2-Amino-2-methyl-3-(1H-1,2,4-triazol-1-yl)propan-1-ol hydrochloride (3)

To oxazoline derivative 2 (1.2 g, 5 mmol) HCl solution (6N, 5 mL) was added and the mixture was refluxed for two hours. After cooling to room temperature, benzoic acid crystals are eliminated by extracting with CH2C12, or ether (2 × 25 mL). The aqueous solution is evaporated to a small volume, treated with water, then concentrated to dryness, then washed with a small quantity of ethanol and, finally, again concentrated to dryness. This compound was obtained as colorless oil. Yield 97%; Mol. Wt: 192.1; 1H-NMR (DMSO-d6, δ ppm): 1.17 (s, 3H, CH3); 3.44, 3.49 (AB, 2H, J = 11.8 Hz, CH2O), 4.52, 4.58 (AB, 2H, J = 14.6 Hz, CH2N), 5.12 (s, 2H, NH2), 8.55 (s, 1Htriazole), 9.34 (s, 1Htriazole); 13C-NMR (CDCl3, δ ppm): 18.84 (CH3), 52.90 (1C, C(CH2OH)), 57.28 (1C, CH2-triazole), 63.46(1C, CH2OH), 147.19 and 149.49 (2C, triazole); MS m/z (%): 192.1 [M] (22), 193.1 (2), 160.1 (100).

3.4. tert-Butyl[1-hydroxy-2-methyl-3-(1H-1,2,4-triazol-1-yl)]propan-2-ylcarbamate (4)

To a cooled (0 < T < 5 °C), solution of aminoalcohol chlorhydrate 3 (1.2 g, 6.3 mmol) in dioxane-water mixture (2/1, 3 mL), triethylamine was added to a neutral pH then Boc2O (2.1 g, 8.24 mmol) was added at the same temperature. The whole mixture is taken to room temperature and left under magnetic agitation for two hours. Dioxane was removed and the aqueous phase extracted with ether, then the organic solution is dried over sodium sulphate and evaporated under reduced pressure. The crude product is chromatographed on silica gel using ether/hexane as eluant to afford the pure N-protected-β-aminoalcohol 4. This compound was obtained as a white powder. Yield 80%; Mol.Wt: 256; Rf = 0.16 (ether/hexane: 3/1); m.p. = 122–124 °C; 1H-NMR (DMSO-d6, δ ppm): 1.18 (s, 3H, CH3), 1.39 (s, 9H, C(CH3)3), 3.35, 3.45 (AB (2dd), 2H, JAB = 10.8 Hz, J3 = 5,6 Hz, CH2O), 4.35, 4.51 (AB, 2H, J = 14 Hz, CH2N), 4.92 (t, 1H, J3 = 5,6 Hz, OH,), 6.29 (s, 1H, NH), 7.95 (s, 1Htriazole), 8.23 (s, 1Htriazole); 13C-NMR (DMSO-d6, δ ppm): 20.43 (CH3), 28.68 (3C, C(CH3)3), 51.74 (1C, C(CH2OH)), 56.66 (1C, CH2-triazole); 64.85 (1C, CH2OH), 78.43 (1C, C(CH3)3), 145.24 and 151.45 (2C, triazole), 154.97 (1C, NHC=O); 15N-NMR (DMSO-d6, δ ppm): 93.29 (NH-1), 214.31 (Ntriazole-7); 252.08 (Ntriazole-10), 299.06 (Ntriazole-8); MS m/z (%) = 257 [M+1] (5), 173.9 (8), 118 (85); 83 (100). Calcd. for C11H20N4O3 (%): C 51.55, H 7.87, N 21.86; Found (%): C 51.41, H 7.81, N 21.74.

3.5. 2-(tert-Butoxycarbonylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic acid (5)

To a mixture of β-aminoalcohol derivative 4 (0.25 g, 1 mmol) and a solution of sodium hydroxide NaOH (0.12 g, 3 mmol) in water (6 mL) was added a solution of potassium permanganate (0.16 g, 1 mmol) in water (8 mL), under vigorous stirring during 4 hours. The mixture was cooled to 4–5 °C by immersion in a bath of ice water, and then the reaction mixture was allowed to gradually attain room temperature. After 12 hours, the precipitate manganese dioxide was filtered off and then the filtrate was cooled. The solution was covered with a layer of ethyl acetate and acidified with dilute sulfuric acid. The ethyl acetate layer was separated and the aqueous layer was extracted three times with ethyl acetate (25 mL). The combined ethyl acetate extracts were dried over anhydrous sodium sulfate. Finally, the ethyl acetate was then removed on a rotavapor. This compound was obtained as a white powder. Yield 92%; Mol.Wt: 270; Rf = 0.08 (ether); m.p. = 188–190 °C; 1H-NMR (DMSO-d6, δ ppm): 1.24 (s, 3H, CH3), 1.40 (s, 9H, C(CH3)3), 4.39, 4.83 (AB, 2H, J = 14 Hz, CH2N), 7.02 (s, 1H, NH)), 7.96 (s, 1Htriazole), 8.20 (s, 1Htriazole), 12.73 (br, 1H, COOH); 13C-NMR (DMSO-d6, δ ppm): 22.33 (CH3), 28.64(3C, C(CH3)3), 52.06 (1C, C(COOH)), 58.24 (1C, CH2-triazole), 78.95 (1C, C(CH3)3), 145.56 and 151.63 (2C, triazole), 155.02 (1C, NHC=O), 174.53(1C, COOH); MS m/z (%): 271 [M+1] (10), 154.1 (24), 83 (100). Calcd. for C11H18N4O4 (%): C 48.88, H 6.71, N, 20.73; Found (%): C 48.76, H 6.57, N 20.71.

4. Conclusions

In conclusion, this work describes the synthesis of a novel heterocycle-substituted amino acid based on using an oxazoline as a masked amino acid. The N-alkylation of 1,2,4-triazole with O-tosyl derivative 1 was occurred under very mild conditions. The regioselectivity was excellent, and only the N1-isomer was obtained.

Acknowledgements

We thank the CNRST Morocco for financial support (Programs PROTAS D13/03). We thank the Presidency for the University for its financial support for the expenses of publication.

References and Notes

  1. Xu, W.; Song, B.; Bhadury, P.; Song, Y.; Hu, D. Synthesis and Crystal Structure of Novel Sulfone Derivatives Containing 1,2,4-Triazole Moieties. Molecules 2010, 15, 766–779. [Google Scholar] [CrossRef]
  2. Karabasanagouda, T.; Adhikari, A.V.; Shetty, N.S. Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4- triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonylphenoxy moieties. Eur. J. Med. Chem. 2007, 42, 521–529. [Google Scholar] [CrossRef]
  3. Tehranchian, S.; Akbarzadeh, T.; Fazeli, M.R.; Jamalifar, H.; Shafiee, A. Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydro benzo[c]thiophen-4(5H)ones. Biol. Med. Chem. Lett. 2005, 15, 1023–1025. [Google Scholar] [CrossRef]
  4. Foroumadi, A.; Soltani, F.; Moshafi, M.H.; Ashraf-Askari, R. Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives. Farmaco 2003, 58, 1023–1028. [Google Scholar] [CrossRef]
  5. Chen, Q.; Zhu, X.L.; Jiang, L.L; Liu, Z.M.; Yang, G.F. Synthesis, antifungal activity and CoMFA analysis of novel1,2,4-triazolo[1,5-a]pyrimidine derivatives. Eur. J. Med. Chem. 2008, 43, 595–603. [Google Scholar] [CrossRef]
  6. Holla, B.S.; Poorjary, K.N.; Rao, B.S.; Shivananda, M.K. New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur. J. Med. Chem. 2002, 37, 511–517. [Google Scholar] [CrossRef]
  7. Yaseen, A.A.-S.; Mohammad, N.A.-D.; Najim, A.A.-M. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco 2004, 59, 775–783. [Google Scholar] [CrossRef]
  8. Demirbas, N.; Ugurluoglu, R.; Demirbas, A. Synthesis of 3-alkyl(Aryl)-4-alkylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-ones and 3-alkyl-4-alkylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones as antitumor agents. Bioorg. Med. Chem. 2002, 10, 3717–3723. [Google Scholar] [CrossRef]
  9. Sun, Q.Y.; Xu, J.M.; Cao, Y.B.; Zhang, W.N.; Wu, Q.Y.; Zhang, D.Z.; Zhang, J.; Zhao, H.Q.; Jing, Y.Y. Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14α-demethylase (CYP51). Eur. J. Med. Chem. 2007, 42, 1226–1233. [Google Scholar] [CrossRef]
  10. Crispino, G.A.; Goudar, J.S. Process for the preparation of a triazolinone herbicide. U.S. Pat. 6,268,506, 31 July 2001. [Chem. Abstr. 2001, 130, 282075].. [Google Scholar]
  11. Song, B.A.; Hu, D.Y.; Zheng, S.; Huang, R.M.; Yang, S.; Huang, J. Synthesis and bioactivity of phosphorodithioate compounds containing 1,2,4-triazole. Chin. J. Org. Chem. 2001, 21, 524–529. [Google Scholar]
  12. Arnold, M.; Evrard, D.; Leander, J.; Lodge, D.; Schoep, D. Tetrazole amino acids as competitive NMDA antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 43–44. [Google Scholar] [CrossRef]
  13. Ebert, B.; Lenz, S.; Brehem, L.; Bregnedal, P.; Hansen, J.; frederiksen, K.; Bogeso, K.; Krosgard-Larsen, P. 1,2,3-Triazolyl Amino Acids as AMPA Receptor Ligands. J. Med. Chem. 1994, 37, 878–884. [Google Scholar] [CrossRef]
  14. Ikegami, F.; Murakoshi, I. Enzymic synthesis of non-protein b-substituted alanines and some higher homologues in plants. Phytochemistry 1994, 35, 1089–1104. [Google Scholar] [CrossRef]
  15. Dunnill, P.; Fowden, L. The amino acids of seeds of the Cucurbitaceae. Phytochemistry 1965, 4, 933–944. [Google Scholar] [CrossRef]
  16. Ferreria, P.M.T.; Maia, H.L.S.; Monterio, L.S. High yielding synthesis of heterocyclic β-substituted alanine derivatives. Tetrahedron Lett. 1999, 40, 4099–4102. [Google Scholar] [CrossRef]
  17. Ferreria, P.M.T.; Maia, H.L.S.; Monterio, L.S.; Sebastiao, J. Michael addition of thiols, carbon nucleophiles and amines to dehydroamino acid and dehydropeptide derivatives. J. Chem. Soc. Perkin Trans. 2001, 1, 3167–3174. [Google Scholar]
  18. Atmani, A.; El Hajji, S.; El Hallaoui, A.; Roumestant, M.L.; Viallefont, Ph. From Oxazolines to Precursors of Aminoacids. Synth. Comm. 1991, 21, 2383–2390. [Google Scholar] [CrossRef]
  19. Zaid, F.; El Hajji, S.; El Hallaoui, A.; Elachqar, A.; Kerbal, A.; Roumestant, M.L.; Viallefont, P. Synthesis of Heterocyclic β-Aminoalcohol Precursors of Heterocyclic α-Aminoacids. Prep. Biochem. Biotechnol. 1998, 28, 137–153. [Google Scholar] [CrossRef]
  20. Zaid, F.; El Hajji, S.; El Hallaoui, A.; Elachqar, A.; Alami, A.; Roumestant, M.L.; Viallefont, P. Synthesis of heterocyclic α-aminoaldehyde and α-aminoacid analogues of Histidines. Prep. Biochem. Biotechnol. 1998, 28, 155–165. [Google Scholar] [CrossRef]
  21. Bulger, P.G.; Cotterell, I.F.; Cowden, C.J.; Davies, A.J.; Dolling, U.H. An investigation into the alkylation of 1,2,4-triazole. Tetrahedron Lett. 2000, 41, 1297–1301. [Google Scholar]
  22. Boukallaba, K.; Elachqar, A.; El Hallaoui, A.; Alami, A.; El Hajji, S.; Labriti, B.; Martinez, J.; Rolland, V. Synthesis of new alpha-heterocyclic alpha-aminophosphonates. Phosphor. Sulfur Silicon 2006, 108, 819–823. [Google Scholar]
  23. Bentama, A.; El Hadrami, E.M.; El Hallaoui, A.; Elachqar, A.; Lavergne, J.P.; Roumestant, M.L.; Viallefont, P. Synthesis of new α-heterocyclic α-aminoesters. Amino Acids 2003, 24, 423–426. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds 1-5 are available from the authors.

Share and Cite

MDPI and ACS Style

Aouine, Y.; Faraj, H.; Alami, A.; El-Hallaoui, A.; Elachqar, A.; Kerbal, A. Simple and Efficient Synthesis of Racemic 2-(tert-Butoxycarbon-ylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic Acid, a New Derivative of β-(1,2,4-Triazol-1-yl)alanine. Molecules 2011, 16, 3380-3390. https://doi.org/10.3390/molecules16043380

AMA Style

Aouine Y, Faraj H, Alami A, El-Hallaoui A, Elachqar A, Kerbal A. Simple and Efficient Synthesis of Racemic 2-(tert-Butoxycarbon-ylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic Acid, a New Derivative of β-(1,2,4-Triazol-1-yl)alanine. Molecules. 2011; 16(4):3380-3390. https://doi.org/10.3390/molecules16043380

Chicago/Turabian Style

Aouine, Younas, Hassane Faraj, Anouar Alami, Abdelilah El-Hallaoui, Abdelrhani Elachqar, and Abdelali Kerbal. 2011. "Simple and Efficient Synthesis of Racemic 2-(tert-Butoxycarbon-ylamino)-2-methyl-3-(1H-1,2,4-triazol-1-yl)propanoic Acid, a New Derivative of β-(1,2,4-Triazol-1-yl)alanine" Molecules 16, no. 4: 3380-3390. https://doi.org/10.3390/molecules16043380

Article Metrics

Back to TopTop